Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration : a pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG)

Thumbnail
Fulltext:
20437___.PDF
Size:
696.5Kb
Format:
PDF
Description:
Publisher’s version
Download
Publication year
1995
Author(s)
Witte, T.J.M. de
Suciu, S.
Peetermans, M.
Fenaux, P.
Strijckmans, P.
Hayat, M.
Jaksic, B.
Selleslag, S.
Zittoun, R.
Dardenne, M.
Solbu, G.
Zwierzina, H.
Muus, P.
Source
Leukemia, 9, 11, (1995), pp. 1805-1811
ISSN
Publication type
Article / Letter to editor
Please use this identifier to cite or link to this item: https://hdl.handle.net/2066/20437   https://hdl.handle.net/2066/20437
Display more details

Upload full text

Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.